The treatment of overactive bladder: A primary care provider’s perspective

被引:1
作者
Matt T. Rosenberg
机构
[1] Mid Michigan Health Centers,
关键词
Lower Urinary Tract Symptom; Overactive Bladder; Tolterodine; Lower Urinary Tract Dysfunction; Invite Commentary;
D O I
10.1007/s11934-008-0073-5
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 22 条
  • [1] Stewart W.F.(2003)Prevalence and burden of overactive bladder in the United States World J Urol 20 327-336
  • [2] Van Rooyen J.B.(2006)Overactive bladder made ridiculously simple? Int J Clin Pract 60 631-633
  • [3] Cundiff G.W.(2006)The sad, misunderstood prostate: understanding perceptions and reality Int J Clin Pract 60 1148-1149
  • [4] Rosenberg M.T.(2008)Master of nothing but knower of all Int J Clin Pract 62 668-669
  • [5] Rosenberg M.T.(2007)Overactive bladder: recognition requires vigilance for symptoms Clev Clin J Med 74 S21-S29
  • [6] Rosenberg M.T.(2007)A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting Int J Clin Pract 61 1535-1546
  • [7] Rosenberg M.T.(2002)The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Am J Obstet Gynecol 187 116-126
  • [8] Newman D.K.(2006)Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial Int J Clin Pract 60 752-758
  • [9] Tallman C.T.(2006)Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial Int J Clin Pract 60 745-751
  • [10] Page S.A.(undefined)undefined undefined undefined undefined-undefined